Literature DB >> 1432126

The treatment of associated intracranial aneurysms and arteriovenous malformations.

M J Cunha e Sa1, B M Stein, R A Solomon, P C McCormick.   

Abstract

Cerebral arterial aneurysm associated with arteriovenous malformation (AVM) has been described with a variable incidence, averaging 10% of AVM cases. The present series includes 39 patients with this association, derived from a total of 400 patients with AVM's evaluated and treated since 1970. The aneurysms are classified into four major groups, each carrying particular therapeutic implications. Optimum treatment of these lesions is based in part on a knowledge of the hemodynamic alterations associated with the AVM's. In most of these cases, the symptomatic lesion was treated first; occasionally, when feasible, both lesions were treated during the same operation. All patients had some form of treatment, either surgical or endovascular, directed to at least one of the two types of lesions. All symptomatic lesions were treated and all ruptured aneurysms were obliterated. There were no deaths in this series.

Entities:  

Mesh:

Year:  1992        PMID: 1432126     DOI: 10.3171/jns.1992.77.6.0853

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  14 in total

1.  Secondary spontaneous thrombosis of a giant aneurysm located distally on a feeding artery after embolization of an associated arteriovenous malformation.

Authors:  W L Poon; H Alvarez; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

2.  Targeted embolization reduces hemorrhage complications in partially embolized cerebral AVM combined with gamma knife surgery.

Authors:  Huo Xiaochuan; Jiang Yuhua; Lv Xianli; Yang Hongchao; Zhao Yang; Li Youxiang
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

3.  Endovascular treatment of intracranial ruptured aneurysms associated with arteriovenous malformations: a clinical analysis of 14 hemorrhagic cases.

Authors:  J-L Yu; S Yang; Q Luo; H-L Wang; B Wang; Y-Y Qu; K Xu
Journal:  Interv Neuroradiol       Date:  2011-04-29       Impact factor: 1.610

4.  Ruptured intrameatal aneurysm of the anterior inferior cerebellar artery accompanying an arteriovenous malformation: a case report.

Authors:  Sun Joo Lee; Jun Seok Koh; Chang Woo Ryu; Seung Hwan Lee
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

5.  Acute rupture of a feeding artery aneurysm after embolization of a brain arteriovenous malformation.

Authors:  Matthew R Reynolds; Eric J Arias; Arindam R Chatterjee; Michael R Chicoine; Dewitte T Cross
Journal:  Interv Neuroradiol       Date:  2015-06-30       Impact factor: 1.610

6.  Iatrogenic rupture of a cerebral aneurysm on the feeding artery of an arteriovenous malformation.

Authors:  R Guzman; L Remonda; K O Lövblad; A Barth; G Schroth
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

7.  Re-growth of a posterior inferior cerebellar artery aneurysm after resection of the associated posterior fossa arteriovenous malformation.

Authors:  Hosam Al-Jehani; Donatella Tampieri; Maria Cortes; Denis Melançon
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

8.  Multi-modality treatment for intracranial arteriovenous malformation associated with arterial aneurysm.

Authors:  Joo Kyung Ha; Seok Keun Choi; Tae Sung Kim; Bong Arm Rhee; Young Jin Lim
Journal:  J Korean Neurosurg Soc       Date:  2009-08-31

9.  A case of ruptured peripheral aneurysm of the anterior inferior cerebellar artery associated with an arteriovenous malformation : a less invasive image-guided transcortical approach.

Authors:  Seung Hwan Lee; Jun Seok Koh; Jae Seung Bang; Gook Ki Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-12-31

10.  Solid vs. cystic predominance in posterior fossa hemangioblastomas: implications for cerebrovascular risks and patient outcome.

Authors:  Samuel Moscovici; Carlos Candanedo; Sergey Spektor; José E Cohen; Andrew H Kaye
Journal:  Acta Neurochir (Wien)       Date:  2021-04-03       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.